Bernd Meibohm
Affiliations: | Pharmaceutical Sciences | University of Tennessee Health Science Center, Memphis, TN, United States |
Area:
Pharmacology, Pharmaceutical ChemistryGoogle:
"Bernd Meibohm"Mean distance: (not calculated yet)
Children
Sign in to add traineeNageshwar R. Budha | grad student | 2009 | UTHSC |
Nathanael L. Dirks | grad student | 2010 | UTHSC |
V. N. Vaddady | grad student | 2011 | UTHSC |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Temrikar ZH, Suryawanshi S, Meibohm B. (2020) Pharmacokinetics and Clinical Pharmacology of Monoclonal Antibodies in Pediatric Patients. Paediatric Drugs |
Fuhr LM, Hanke N, Meibohm B, et al. (2020) Effective Removal of Dabigatran by Idarucizumab or Hemodialysis: A Physiologically Based Pharmacokinetic Modeling Analysis. Clinical Pharmacokinetics |
Shakhnovich V, Meibohm B, Rosenberg A, et al. (2019) Immunogenicity in Clinical Practice and Drug Development: When is it Significant? Clinical and Translational Science |
Nagesh PKB, Chowdhury P, Hatami E, et al. (2019) Cross linked polyphenol-based drug nano-self assemblies engineered to blockade prostate cancer senescence. Acs Applied Materials & Interfaces |
Walz A, Lukka PB, Pearce C, et al. (2019) Sterilization of Mycobacterium tuberculosis infected samples using methanol preserves anti-tuberculosis drugs for subsequent pharmacological testing studies. Tuberculosis (Edinburgh, Scotland). 117: 52-55 |
Stewart IE, Lukka PB, Liu J, et al. (2019) Development and Characterization of a Dry Powder Formulation for Anti-Tuberculosis Drug Spectinamide 1599. Pharmaceutical Research. 36: 136 |
Donnenberg VS, Chaikin P, Mandic M, et al. (2019) Core Entrustable Professional Activities in Clinical Pharmacology for Entering Residency: Common Problem Drugs and How to Prescribe Them. Journal of Clinical Pharmacology |
Rathi C, Lukka PB, Wagh S, et al. (2019) Comparative pharmacokinetics of spectinamide 1599 after subcutaneous and intrapulmonary aerosol administration in mice. Tuberculosis (Edinburgh, Scotland). 114: 119-122 |
Vaddady PK, Trivedi A, Rathi C, et al. (2018) Dynamic time-kill curve characterization of spectinamide antibiotics 1445 and 1599 for the treatment of tuberculosis. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences |
Santos K, Lukka PB, Grzegorzewicz A, et al. (2018) Primary Lung Dendritic Cell Cultures to Assess Efficacy of Spectinamide-1599 Against Intracellular . Frontiers in Microbiology. 9: 1895 |